REQUEST A DEMO
Total
USD $0.00
Search more companies

Lumimedik Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lumimedik Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Lumimedik Sdn. Bhd. is a company in Malaysia, with a head office in Petaling Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on November 10, 2017. From the latest financial highlights, Lumimedik Sdn. Bhd. reported a net sales revenue increase of 126.31% in 2021. Over the same period, its total assets decreased by 57.48%. In 2021, Lumimedik Sdn. Bhd.’s net profit margin increased by 5.21%.

Headquarters
C-9-31, Centum Oasis Corporate Park, No.2 Jalan Pju 1A/2, Oasis Damansara
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Lumimedik Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Lumimedik Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Lumimedik Sdn. Bhd. report to view the information.
Incorporation Date:
November 10, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lumimedik Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
126.31%
Total operating revenue
126.31%
Operating profit (EBIT)
734.89%
EBITDA
753.75%
Net Profit (Loss) for the Period
708.6%
Total assets
-57.48%
Total equity
226.02%
Operating Profit Margin (ROS)
6.79%
Net Profit Margin
5.21%
Return on Equity (ROE)
32%
Quick Ratio
0.61%
Cash Ratio
-0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?